Silicon Laboratories, Inc. — Earnings Quality Grade F
SLAB · Technology
Major red flags
Screening Summary
管理层信号
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 30 days, change -4 days YoY
AR growth 18.4% vs revenue growth 34.3%
Revenue 34.3%, CFFO 788.1%. Cash follows revenue
Expense Quality
Inventory -9.5% vs COGS 20.4%. Normal
CapEx growth 154.7% is >2x revenue growth 34.3%
SG&A/Gross Profit = 38.1%. Normal
Gross margin 58.2%, change +4.8pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
FCF $0.1B, FCF/NI = -1.01
Insufficient data
Cash $0.4B covers debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.4B = 37% of equity
Interest coverage = -72.3x (<2x). Financial stress
Other assets -11.2% vs revenue 34.3%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles change -3% YoY. Normal
Manipulation Score
Insufficient data
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25